Latest Stories

G
Three Reasons

Acushnet (GOLF): Buy, Sell, or Hold Post Q3 Earnings?

Acushnet has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 18.7% to $85.50 per share while the index has gained 13.9%.

Dec 12, 2025
L
Three Reasons

LendingClub (LC): Buy, Sell, or Hold Post Q3 Earnings?

LendingClub has been on fire lately. In the past six months alone, the company’s stock price has rocketed 86.5%, setting a new 52-week high of $20.50 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Dec 12, 2025
L
Three Reasons

3 Reasons to Sell LYV and 1 Stock to Buy Instead

Since June 2025, Live Nation has been in a holding pattern, floating around $141.94. The stock also fell short of the S&P 500’s 13.9% gain during that period.

Dec 12, 2025
F
Three Reasons

3 Reasons to Avoid FCF and 1 Stock to Buy Instead

Even though First Commonwealth Financial (currently trading at $17.20 per share) has gained 8.2% over the last six months, it has lagged the S&P 500’s 13.9% return during that period. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

Dec 12, 2025
W
Three Reasons

3 Reasons WAL is Risky and 1 Stock to Buy Instead

Western Alliance Bancorporation has had an impressive run over the past six months as its shares have beaten the S&P 500 by 5.8%. The stock now trades at $88.35, marking a 19.7% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Dec 12, 2025
N
Three Reasons

3 Reasons NLY is Risky and 1 Stock to Buy Instead

Annaly Capital Management trades at $22.31 per share and has stayed right on track with the overall market, gaining 14.5% over the last six months. At the same time, the S&P 500 has returned 13.9%.

Dec 12, 2025
M
Three Reasons

2 Reasons to Sell MMSI and 1 Stock to Buy Instead

Over the past six months, Merit Medical Systems’s stock price fell to $86.89. Shareholders have lost 7.1% of their capital, which is disappointing considering the S&P 500 has climbed by 13.9%. This may have investors wondering how to approach the situation.

Dec 12, 2025
C
Post-Earnings

Sales And Marketing Software Stocks Q3 Earnings: Sprinklr (NYSE:CXM) Best of the Bunch

Looking back on sales and marketing software stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Sprinklr (NYSE:CXM) and its peers.

Dec 12, 2025
A
Post-Earnings

Data Infrastructure Stocks Q3 Teardown: C3.ai (NYSE:AI) Vs The Rest

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at C3.ai (NYSE:AI) and its peers.

Dec 12, 2025
Q
Post-Earnings

Cybersecurity Stocks Q3 Earnings Review: Qualys (NASDAQ:QLYS) Shines

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the cybersecurity industry, including Qualys (NASDAQ:QLYS) and its peers.

Dec 12, 2025